Knights of Columbus Asset Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-24,075
Closed -$2.46M 408
2025
Q4
$2.46M Sell
24,075
-801
-3% -$71.7K 0.14% 159
2025
Q3
$1.55M Buy
+24,876
New +$1.35M 0.09% 228
2024
Q1
Sell
-79,026
Closed -$2.14M 381
2023
Q4
$2.14M Buy
79,026
+41,059
+108% +$1.08M 0.14% 225
2023
Q3
$1.13M Buy
37,967
+31,778
+513% +$1.12M 0.1% 232
2023
Q2
$222K Hold
6,189
0.02% 313
2023
Q1
$145K Hold
6,189
0.01% 315
2022
Q4
$168K Buy
+6,189
New +$283K 0.02% 304
2021
Q1
Sell
-20,237
Closed -$2.61M 333
2020
Q4
$2.61M Buy
+20,237
New +$2.33M 0.28% 126

Other funds holding GH

Knights of Columbus Asset Advisors's GH Position: Q1 2026 in Review

Knights of Columbus Asset Advisors sold out of Guardant Health (GH) in Q1 2026, closing a stake of 24,075 shares — an estimated $2.46M sold.

Knights of Columbus Asset Advisors first reported a position in GH in Q4 2020 and held it in 8 quarters. The position peaked at $2.61M in Q4 2020. 483 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Knights of Columbus Asset Advisors reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 24,075 Guardant Health shares in Q1 2026, an estimated $2.46M.
  • Knights of Columbus Asset Advisors first reported a position in Guardant Health in Q4 2020 and held it in 8 quarters.
  • Knights of Columbus Asset Advisors's Guardant Health position peaked at $2.61M in Q4 2020.
  • 483 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q1 2026, filed 11 May 2026.